Product Information
GLIPIZIDE 5 MG TABLET is a generic product labeled by Oxford Pharmaceuticals, LLC, priced at $0.0339 per EA under NDC 69584030950. Its NADAC has been published 56 times since Sep 10, 2025.
FDA first approved this application on Nov 28, 1994. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Oxford Pharmaceuticals, LLCNDC
69584030950
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GLIPIZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074378FDA Approved
11/28/1994
TE Code
AB
On Market Since
5/1/2025
Pharmacological Classes
Price Statistics
The NADAC for GLIPIZIDE 5 MG TABLET has been published 56 times since Sep 10, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0339 per EA |
|---|---|
| All-time high | $0.0360 (May 13, 2026) |
| All-time low | $0.0339 (Sep 23, 2026) |
| 52-week high | $0.0360 |
| 52-week low | $0.0339 |
| Median price | $0.0356 |
| Average price | $0.0354 |
| Largest weekly change | -3.1% (Sep 23, 2026) |
| Weeks tracked | 56 |
| Tracking since | Sep 10, 2025 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Oxford Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Glipizide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfonylurea class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GLIPIZIDE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLIPIZIDE 5 MG TABLET, manufactured by Oxford Pharmaceuticals, LLC, is $0.0339 per EA (NDC 69584030950), effective Sep 30, 2026.
How has the price of GLIPIZIDE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLIPIZIDE 5 MG TABLET has held within roughly two percent of its current level. It has been tracked across 56 weekly CMS publications since Sep 10, 2025.
What are the highest and lowest recorded NADAC prices for GLIPIZIDE 5 MG TABLET?
Since Sep 10, 2025, the NADAC for GLIPIZIDE 5 MG TABLET has ranged from a low of $0.0339 (Sep 23, 2026) to a high of $0.0360 (May 13, 2026), with a median of $0.0356 per EA.
Are there cheaper alternatives to GLIPIZIDE 5 MG TABLET?
12 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GLIPIZIDE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures GLIPIZIDE 5 MG TABLET?
GLIPIZIDE 5 MG TABLET (NDC 69584030950) is labeled by Oxford Pharmaceuticals, LLC, and CMS classifies it as a generic product.